Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-site, Prospective, Clinical Performance Evaluation of NxTekTM Malaria Pf Plus Rapid Diagnostic Test Device and NxTekTM Malaria Pf/Pv Plus Rapid Diagnostic Test (RDT) Device for the Detection of Plasmodium Infections in Patients With Symptoms Suggestive of Malaria

NCT05286359 is registered in ClinicalTrials.gov with Abbott Rapid Dx as lead sponsor.

NCT NCT05286359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05286359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-site, Prospective, Clinical Performance Evaluation of NxTekTM Malaria Pf Plus Rapid Diagnostic Test Device and NxTekTM Malaria Pf/Pv Plus Rapid Diagnostic Test (RDT) Device for the Detection of Plasmodium Infections in Patients With Symptoms Suggestive of Malaria
Lead sponsor
Abbott Rapid Dx
Phase
Not applicable
Overall status
Completed
Start date
May 24, 2022
Completion date
November 17, 2022
Enrollment
1,023 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria